Equine Sports Council

Controlled Medications Library

ESC MEDICATION CLASSIFICATIONClass A - Therapeutic

ESC Medication Library · Revision 3

← Medication library · Compare sanctioning bodies

Pentoxyfylline

Medication Facts

Performance enhancing
No
Total hours to clear
Not recorded
Frequently used
Most Prescribed
ESC ID
PENTOX-0687
Trade names
Trental
Drug type
Vasodilator
Plasma half-life · hours
1.5
Equine dosing
7.5 to 10 mg/kg PO twice daily (every 12 hours). Navicular
Cmax · peak plasma concentration
1 to 9 ng/mL
Tmax · time to peak plasma concentration
1 hour
ESC concentration guidance
1 to 9 ng/mL
Primary withdrawal · hours
0
Washout withdrawal · hours
0
ESC control type
A1 - Generally Controlled - Therapeutic
Medication report required
Generally not required, however understand exceptions.

Uses & side effects

Promotes Blood Flow to Hooves & Uterous

Drug interactions

Pentoxifylline can interact with several drugs in horses, primarily because it affects blood flow, platelet function, and circulation. While equine-specific interaction studies are limited, veterinary references and pharmacology data suggest caution with the following combinations:

NSAIDs (such as phenylbutazone/Bute, flunixin/Banamine, firocoxib/Equioxx)
Combining pentoxifylline with NSAIDs may increase the risk of gastrointestinal irritation, ulceration, or bleeding because both can affect blood flow and platelet activity. Monitoring is advised, especially in dehydrated horses or long-term use cases.
Anticoagulants or antiplatelet drugs
Pentoxifylline may increase bleeding risk when used with medications that thin the blood or reduce clotting. This includes aspirin or heparin-type therapies.
Theophylline or caffeine-like drugs (xanthines)
Pentoxifylline is chemically related to xanthines and may increase the effects or blood levels of theophylline, potentially causing excitability, tremors, sweating, or elevated heart rate.

Contraindications

Government Numbers

Pentoxifylline ER 400 mg: human prescription product; ANDA 074878; NDC 70954-668-10 (100 tablets) and 70954-668-20 (500 tablets). Labeler: ANI Pharmaceuticals, Inc. These identifiers do not establish equine approval or an equine dose. Label updated November 7, 2025; reviewed September 18, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9ca79c97-e4e5-4297-85eb-7a9b3d8083b5

Sanctioning-body comparison

Plasma only. Compare published competition guidance for this medication. ESC guidance remains in Medication Facts above. A dosing guideline, withdrawal recommendation and laboratory detection threshold are different measures.

Sources reviewed September 23, 2026. “Not verified” means a gap in this comparison, not zero tolerance or permission. Doses describe the cited rules; your veterinarian must determine treatment and withdrawal.

Published guidance by organization
OrganizationPublished dose & routePlasma concentrationWithdrawal / timingControl / penalty class
AQHA Show HorsesShow rules · 2026 handbook
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
APHA Paint Show HorsesShow rules · 2026 Rule Book
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
ARCI Model RulesRacing model · Rules 15 / UCG 20.0 / CTMS 4.2.1
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules. ARCI model comparison only; no state-specific rule is substituted. Schedule timing is tied to its stated regimen and is not a clearance guarantee.

UCG 20.0 PDF p. 44

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Drug Class 4 · Penalty Class D. No dosing permission is implied by classification.
USEFNational Therapeutic Substance Provisions · 2026 + July amendment
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.